1 period filed. Holdings below describe the selected month only.
NPORT-P · filed 2026-04-28
2 classes of this one portfolio · 1 exchange-listed
| Class ID | Symbol | Status | Security in the master | Type |
|---|---|---|---|---|
| C000012223 | VHT | LINKEDSEC_TICKER | VHTVanguard Health Care ETF | ETF |
| C000012222 | VHCIX | NOT_LISTED | not exchange-listed | — |
N-PORT Item C.4.a
N-PORT Item C.4.b
as filed
Positions resolved to the master through ISIN, then rolled up through the taxonomy. 98.7% of reported value reaches a classification.
Percentages are of the reported value of positions above ($20.24B), not of the fund’s net assets ($20.27B). The two differ by cash, derivatives filed with no market value, and rounding.
416 positions in this filing
| Issuer↕ | In master | CUSIP / ISIN | Asset | Balance↕ | Value↕ | Weight▼ | Country |
|---|---|---|---|---|---|---|---|
| 4D Molecular Therapeutics Inc 4D MOLECULAR THE | FDMT | 35104E100 US35104E1001 | EC CORP | 105,389 NS | $1.02M | 0.005% | US |
| OrthoPediatrics Corp ORTHOPEDIATRICS | KIDS | 68752L100 US68752L1008 | EC CORP | 52,580 NS | $1.01M | 0.005% | US |
| MeiraGTx Holdings plc MEIRAGTX HOLDING | MGTX | G59665102 KYG596651029 | EC CORP | 131,531 NS | $994.4K | 0.005% | US |
| Akebia Therapeutics Inc AKEBIA THERAPEUT | AKBA | 00972D105 US00972D1054 | EC CORP | 757,990 NS | $993.0K | 0.005% | US |
| Evolent Health Inc EVOLENT HEALTH-A | EVH | 30050B101 US30050B1017 | EC CORP | 300,475 NS | $976.5K | 0.005% | US |
| Septerna Inc SEPTERNA INC | SEPN | 81734D104 US81734D1046 | EC CORP | 33,480 NS | $971.6K | 0.005% | US |
| Bicara Therapeutics Inc BICARA THERAPEUT | BCAX | 055477103 US0554771032 | EC CORP | 57,294 NS | $961.4K | 0.005% | US |
| Fulcrum Therapeutics Inc FULCRUM THERAPEU | FULC | 359616109 US3596161097 | EC CORP | 113,751 NS | $953.2K | 0.005% | US |
| Fulgent Genetics Inc FULGENT GENETICS | FLGT | 359664109 US3596641098 | EC CORP | 59,813 NS | $916.9K | 0.005% | US |
| Aldeyra Therapeutics Inc ALDEYRA THERAPEU | ALDX | 01438T106 US01438T1060 | EC CORP | 155,899 NS | $851.2K | 0.004% | US |
| Standard BioTools Inc STANDARD BIOTOOL | LAB | 34385P108 US34385P1084 | EC CORP | 747,537 NS | $844.7K | 0.004% | US |
| SIGA Technologies Inc SIGA TECH INC | SIGA | 826917106 US8269171067 | EC CORP | 130,376 NS | $843.5K | 0.004% | US |
| Quanterix Corp QUANTERIX CORP | QTRX | 74766Q101 US74766Q1013 | EC CORP | 125,718 NS | $823.5K | 0.004% | US |
| Lexicon Pharmaceuticals Inc LEXICON PHARMACE | LXRX | 528872302 US5288723027 | EC CORP | 548,799 NS | $806.7K | 0.004% | US |
| Ardent Health Partners Inc ARDENT HEALTH IN | ARDT | 03980N107 US03980N1072 | EC CORP | 85,780 NS | $805.5K | 0.004% | US |
| RxSight Inc RXSIGHT INC | RXST | 78349D107 US78349D1072 | EC CORP | 104,675 NS | $783.0K | 0.004% | US |
| Cross Country Healthcare Inc CROSS COUNTRY HE | — | 227483104 US2274831047 | EC CORP | 88,741 NS | $772.0K | 0.004% | US |
| Aura Biosciences Inc AURA BIOSCIENCES | AURA | 05153U107 US05153U1079 | EC CORP | 130,798 NS | $770.4K | 0.004% | US |
| XOMA Royalty Corp XOMA ROYALTY COR | — | 98419J206 US98419J2069 | EC CORP | 29,011 NS | $740.7K | 0.004% | US |
| Verastem Inc VERASTEM INC | VSTM | 92337C203 US92337C2035 | EC CORP | 129,463 NS | $740.5K | 0.004% | US |
| Atea Pharmaceuticals Inc ATEA PHARMACEUTI | AVIR | 04683R106 US04683R1068 | EC CORP | 155,056 NS | $725.7K | 0.004% | US |
| Keros Therapeutics Inc KEROS THERAPEUTI | KROS | 492327101 US4923271013 | EC CORP | 49,534 NS | $702.9K | 0.003% | US |
| Rezolute Inc REZOLUTE INC | RZLT | 76200L309 US76200L3096 | EC CORP | 218,368 NS | $701.0K | 0.003% | US |
| Entrada Therapeutics Inc ENTRADA THERAPEU | TRDA | 29384C108 US29384C1080 | EC CORP | 57,598 NS | $687.1K | 0.003% | US |
| Ginkgo Bioworks Holdings Inc GINKGO BIOWORKS | DNA | 37611X209 US37611X2099 | EC CORP | 99,142 NS | $669.2K | 0.003% | US |
| Simulations Plus Inc SIMULATIONS PLUS | SLP | 829214105 US8292141053 | EC CORP | 52,274 NS | $639.3K | 0.003% | US |
| Evolus Inc EVOLUS INC | EOLS | 30052C107 US30052C1071 | EC CORP | 144,566 NS | $621.6K | 0.003% | US |
| Organogenesis Holdings Inc ORGANOGENESIS HO | ORGO | 68621F102 US68621F1021 | EC CORP | 190,756 NS | $612.3K | 0.003% | US |
| Arcturus Therapeutics Holdings Inc ARCTURUS THERAPE | ARCT | 03969T109 US03969T1097 | EC CORP | 73,875 NS | $608.0K | 0.003% | US |
| Neumora Therapeutics Inc NEUMORA THERAPEU | NMRA | 640979100 US6409791000 | EC CORP | 171,100 NS | $597.1K | 0.003% | US |
| Editas Medicine Inc EDITAS MEDICINE | EDIT | 28106W103 US28106W1036 | EC CORP | 270,431 NS | $594.9K | 0.003% | US |
| OraSure Technologies Inc ORASURE TECH | OSUR | 68554V108 US68554V1089 | EC CORP | 188,856 NS | $594.9K | 0.003% | US |
| Alector Inc ALECTOR INC | ALEC | 014442107 US0144421072 | EC CORP | 241,487 NS | $586.8K | 0.003% | US |
| Accendra Health Inc ACCENDRA HEALTH | ACH | 690732102 US6907321029 | EC CORP | 232,854 NS | $563.5K | 0.003% | US |
| Lyell Immunopharma Inc LYELL IMMUNOPHAR | LYEL | 55083R203 US55083R2031 | EC CORP | 23,103 NS | $554.5K | 0.003% | US |
| agilon health Inc AGILON HEALTH IN | — | 00857U107 US00857U1079 | EC CORP | 938,023 NS | $552.8K | 0.003% | US |
| Humacyte Inc HUMACYTE INC | HUMA | 44486Q103 US44486Q1031 | EC CORP | 478,723 NS | $533.8K | 0.003% | US |
| N/A TRS:JOHNSON & JOHNSON USD 2027-Jan-29 | — | — — | DE OTHER | 100,000 NC | $510.0K | 0.003% | N/A |
| Heron Therapeutics Inc HERON THERAPEUTI | HRTX | 427746102 US4277461020 | EC CORP | 418,992 NS | $498.6K | 0.002% | US |
| GoodRx Holdings Inc GOODRX HOLDIN-A | GDRX | 38246G108 US38246G1085 | EC CORP | 259,964 NS | $486.1K | 0.002% | US |
| Atrium Therapeutics Inc ATRIUM THERAPEUT | RNA | 04965N104 US04965N1046 | EC CORP | 32,849 NS | $484.5K | 0.002% | US |
| LENZ Therapeutics Inc LENZ THERAPEUTIC | LENZ | 52635N103 US52635N1037 | EC CORP | 35,168 NS | $474.4K | 0.002% | US |
| Quantum-Si Inc QUANTUM-SI INC | QSI | 74765K105 US74765K1051 | EC CORP | 493,459 NS | $471.9K | 0.002% | US |
| OmniAb Inc OMNIAB INC | OABI | 68218J103 US68218J1034 | EC CORP | 259,648 NS | $446.6K | 0.002% | US |
| Fate Therapeutics Inc FATE THERAPEUTIC | FATE | 31189P102 US31189P1021 | EC CORP | 295,141 NS | $436.8K | 0.002% | US |
| Zentalis Pharmaceuticals Inc ZENTALIS PHARMAC | ZNTL | 98943L107 US98943L1070 | EC CORP | 151,885 NS | $363.0K | 0.002% | US |
| Health Catalyst Inc HEALTH CATALYST | HCAT | 42225T107 US42225T1079 | EC CORP | 210,413 NS | $340.9K | 0.002% | US |
| N/A TRS:MODERNA INC USD 2026-Aug-31 | — | — — | DE OTHER | 145,000 NC | $319.0K | 0.002% | N/A |
| Upstream Bio Inc UPSTREAM BIO INC | UPB | 91678A107 US91678A1079 | EC CORP | 40,484 NS | $310.9K | 0.002% | US |
| MacroGenics Inc MACROGENICS INC | MGNX | 556099109 US5560991094 | EC CORP | 155,000 NS | $308.4K | 0.002% | US |